摘要
维生素D是一种脂溶性维生素.作为固醇类衍生物.一定程度上起到类固醇激素的作用,包括调节钙磷代谢、维持骨稳态、免疫调节、抗炎症、抗纤维化、抗肿瘤等。肝脏在维生素D的合成、代谢以及发挥生物学效应中起重要作用。机体维生素D的状况和它的多效性使之与各种慢性肝病(Chronicliverdis—ease,v,,CLDs)的发病机制、严重程度和治疗效果相关。
出处
《肝脏》
2013年第10期714-717,共4页
Chinese Hepatology
参考文献28
-
1Kitson MT, Roberts SK. D-livering the message: The importance of vitamin D status in chronic liver disease. Hepatology, 2012, 57: 897-909.
-
2Margheita T, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med, 2004,229: 1136-1142..
-
3Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets, 2011,12: 4-18.
-
4Holick MF, Vitamin D Deficiency. N Eng J Med, 2007,357:266-281.
-
5Hewison M. An update on vitamin D and human immunity. Clin Endocrinol(oxf), 2012, 76:315-325.
-
6Do JE, Kwon SY, Park S,et al. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology (Oxford), 2008,47 : 840-848.
-
7Dickie LJ, Church LD, Coulthard LR, et al. Vitamin D3 down- regulates intracellular Toll-like receptor 9 induced IL 6 production in human monocytes. Rheumatology ( Oxford), 20/0, 49 : 1466-1471.
-
8Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treat ment of trinitrobenzene sulfonic acid colitis with calcitriol is associ ated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther, 2008, 324:23-33.
-
9Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25 di hydroxyvitamin D3 on human B cell differentiation. Journal of Im munology, 2007,179 : 1634-1647.
-
10Vanoirbeek E, Krishnan A, Eelen G, et al. The anti-cancer and anti inflammatory actions of 1,25(OH)2D3. Clinical Endocrinology and Metabolism, 2011,25 : 593-604.
二级参考文献12
-
1van Etten E,Branisteanu DD,Verstuyf A,et al.Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants.Transplantation,2000,69:1932-1942.
-
2Giarratana N,Penna G,Amuchastegui S,et al.A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.J Immunol,2004,173:2280-2287.
-
3Cippitelli M,Fionda C,Di Bona D,et al.Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.J Immunol,2002,168:1154-1166.
-
4An International Panel.Banff schema for grading liver allograft rejection:an international consensus document.Hepatology,1997,25:658-663.
-
5Funaki H,Shimizu K,Harada S,et al.Essential role for nuclear factor kappa B in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver.Transplantation,2002,74:551-556.
-
6Aggarwal BB.Signalling pathways of the TNF superfamily:a doubleedged sword.Nat Rev Immunol,2003,3:745-756.
-
7Lin L,Spoor MS,Gerth AJ,et al.Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxjl.Science,2004,303:1017-1020.
-
8Beyaert R,Heyninck K,Van Huffel S.A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.Biochem Pharmacol,2000,60:1143-1151.
-
9Saitoh T,Yamamoto M,Miyagishi M,et al.A20 is a negative regulator of IFN regulatory factor 3 signaling.J Immunol,2005,174:1507-1512.
-
10Wertz IE,O' Rourke KM,Zhou H,et al.De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappa B signalling.Nature,2004,430:694 -699.
共引文献5
-
1方振宇,杨涛.1,25-二羟维生素D_3的免疫调节机制及其在肝移植中应用的研究现状[J].实用器官移植电子杂志,2014,2(2):90-92.
-
2胡雁,周善璧.1,25-二羟维生素D_3抑制大鼠角膜移植术后免疫排斥反应[J].第三军医大学学报,2008,30(23):2211-2214. 被引量:3
-
3解玉军,高晓唯,李文静.1,25二羟基维生素D_3对兔角膜碱烧伤朗格罕氏细胞影响[J].现代生物医学进展,2011,11(5):854-856.
-
4胡续光,南今娘,李洪秀.中国肝移植后排斥反应研究的发展趋势[J].中国组织工程研究,2012,16(31):5861-5870.
-
5杨龙,张雅敏,沈中阳.锌指蛋白A20对移植相关的肝脏病理生理调节作用的研究进展[J].中华器官移植杂志,2017,38(9):573-575.
同被引文献9
-
1黄瑾,王玲,曾建强,王卓.维生素K1在肝硬化失代偿患者中应用的药学监护[J].中国新药杂志,2009,18(2):181-182. 被引量:8
-
2杨国辉,雷招宝.维生素K_1注射液致过敏性休克45例分析[J].临床合理用药杂志,2009,2(18):47-48. 被引量:30
-
3Mikkel Malham,SΦren Peter JΦrgensen,Peter Ott,JΦrgen Agnholt,Hendrik Vilstrup,Mette Borre,Jens F Dahlerup.Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology[J].World Journal of Gastroenterology,2011,17(7):922-925. 被引量:16
-
4黄琳,李泮海,田月洁.156例维生素K_1注射液致严重不良反应分析[J].中国药房,2011,22(32):3047-3050. 被引量:24
-
5王治涛.静注维生素K1致小儿过敏性休克1例报告并文献复习[J].华中科技大学学报(医学版),2011,40(4):502-503. 被引量:5
-
6裴振峨,杨乐,纪立伟,肖爱丽,孟永成,杜晓曦.维生素K_1注射液的安全性[J].临床药物治疗杂志,2011,9(5):44-46. 被引量:24
-
7薛晓琳,王天芳,李昕,张琳,吴秀艳.从“肝藏血主疏泄”功能失调角度探讨肝硬化的发生机理[J].世界中医药,2013,8(2):121-124. 被引量:17
-
8颜秀娟.维生素K1注射液滴壶给药致不良反应20例原因分析[J].中国民族民间医药,2013,22(21):92-92. 被引量:1
-
9张艳茹,赖静兰,张浩,王俊洁,齐明华,于乐成,周元平.基线维生素D与慢性丙型肝炎持久病毒学应答相关性的Meta分析[J].肝脏,2014,19(2):91-94. 被引量:1
二级引证文献3
-
1戈宏焱,姜浩.蒙药清肝九味散对酒精性肝炎患者血清基质金属蛋白酶抑制剂-1水平的影响[J].实用肝脏病杂志,2016,19(6):720-721. 被引量:6
-
2姜浩,戈宏焱.熊去氧胆酸联合脂溶性维生素注射液治疗酒精性肝病伴肝内胆汁淤积患者疗效观察[J].实用肝脏病杂志,2017,20(1):105-106. 被引量:15
-
3熊壮,刘扬扬,霍少凯,宫嘉莲,金天一,王强,王慧林,刘铁军,冷炎.维生素K1治疗肝衰竭凝血功能障碍的研究进展[J].临床肝胆病杂志,2019,35(9):2099-2103. 被引量:9
-
1李洁廉.维生素D帮您改善血糖控制[J].糖尿病之友,2008(1):64-64.
-
2夏伟,曾甫清.肝细胞生长因子在肾移植中的应用[J].国际泌尿系统杂志,2006,26(4):464-467. 被引量:1
-
3崔瑞.维生素D不足或使人早亡[J].医药前沿,2014,0(20):47-47.
-
4应酬多让胆囊消受不起[J].家庭健康(医学科普),2013(2):5-5.
-
5丁怡.维生素D在2型糖尿病发病机制中的作用[J].中国医师进修杂志,2011,34(36):52-54. 被引量:1
-
6周惠琼.骨质疏松症问答[J].中老年保健,2011(9):18-19.
-
7杨霞,万建新.促红细胞生成素对肾脏保护的多效性[J].临床肾脏病杂志,2010(3):138-140.
-
8孟迅吾.维生素D和活性维生素D对跌倒和骨质疏松性骨折的预防作用[J].中华老年医学杂志,2012,31(7):630-633. 被引量:6
-
9龚莉华,张爱华,周黎纹.血清维生素D水平与2型糖尿病视网膜病变程度的相关性研究[J].眼科,2016,25(4):270-271. 被引量:3
-
10龙建竹,陈树,杨明,王均慷,张敏,陈平,向露.老年2型糖尿病伴骨质疏松症2例报告并文献复习[J].实用医院临床杂志,2011,8(6):221-222.